|Stage of funding:||Current|
OCON Medical – an Israel-based company specializing in development of novel medical devices for women health. OCON Medical develops and manufactures unique intra uterine products based on the Company’s proprietary innovative IUB™ platform (Intra Uterine Ball). The IUB™ is made of a super-elastic alloy which is an ideal carrier for multiple substances and indications. Initial products marketed by the Company are indicated for long term reversible contraception (LARC). The company is actively developing additional products for multiple indications.
NovaDigm Therapeutics, a company developing innovative immunotherapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees. The study is being conducted with the Uniformed Services University of the Health Sciences (USU) and is enrolling U.S. Army Infantry trainees at Fort Benning, GA. NDV-3A is the company’s lead development candidate to potentially treat antimicrobial resistant fungal and bacterial pathogens.
12 April 2018
30 March 2018
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect™ Test in Patients with Metastatic Castration-Resistant Prostate Cancer
14 March 2018